In 2026, the USA did not produce pharmaceutical active pharmaceutical ingredients — the figure was 0 tonnes. This is paradoxical for a country with the world's largest pharmaceutical industry, but it is explained by the global division of labor: American companies prefer to locate the production of active pharmaceutical ingredients in Poland, Romania, and Portugal, where costs are lower and environmental regulations are stricter. Only the final stages — mixing, dosing, and packaging — remain in the USA. In the global ranking, the country holds 33-th place out of 197.
USA world ranking
Country position on the scale from last to first place for this indicator.
Change over time
Change in indicator over the available period.
Values — tonnes
Top countries by Pharmaceutical active pharmaceutical ingredients (APIs) production
Where USA stands in the world ranking.
People also search for
Other pages of the reference by this indicator.